Exelgyn is a global pharmaceutical company specialising in women’s healthcare. Its mission is to further improve healthcare for women worldwide and give them more autonomy. The company is known to be a pioneer in medical termination of pregnancy in Europe and export market and continue striving to ensure women access to this safe and effective method.
Currently, Exelgyn’s products (registered on the WHO list of essential medicines) are marketed in more than 30 countries which has enabled millions of women to terminate their unwanted pregnancy.
Exelgyn is committed to support both healthcare professionals and women throughout each step of a medical termination of pregnancy. Exelgyn intends to communicate smartly to make sure that patients and physicians have the information they need to make appropriate choices about abortion methods.
The scientific committee is composed of European gynaecologists/obstetricians:
Christian FIALA (Austria)
Marek LUBUSKY (Czech Republic)
Aubert AGOSTINI (France)
Mirella PARACHINI (Italy)
Teresa BOMBAS (Portugal)
We want to thank all our correspondents, former and present, who have kindly accepted to help us collect the data presented on the website (e.g., abortion statistics), in particular those mentioned below for their latest contribution to keep the website up-to-date:
Nausikaä MARTENS (Belgium)
Vesna STEPANIC (Croatia)
Charlotte WILKEN-JENSEN (Denmark)
Helle KARRO (Estonia)
Ines THONKE (Germany)
Gyula CSERMELY (Hungary)
Diana RAMASAUSKAITE and Raminta BAUSYTE (Lithuania)
Mette LØKELAND (Norway)
Krystyna KACPURA (Poland)
Aleksandra KAPAMADZIJA (Serbia)
Bojana PINTER (Slovenia)
Kristina GEMZELL-DANIELSSON (Sweden)
Helene HULDI (Switzerland)
Monique OPHEIJ (The Netherlands)